Publicacións nas que colabora con Eva Mª Villaron Rios (14)

2012

  1. Allogeneic mesenchymal stem cell therapy for refractory cytopenias after hematopoietic stem cell transplantation

    Transfusion, Vol. 52, Núm. 5, pp. 1086-1091

  2. Optimisation of mesenchymal stromal cells karyotyping analysis: Implications for clinical use

    Transfusion Medicine, Vol. 22, Núm. 2, pp. 122-127

2009

  1. Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome

    Leukemia, Vol. 23, Núm. 4, pp. 664-672

2008

  1. Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification

    Experimental Hematology, Vol. 36, Núm. 8, pp. 1014-1021

2007

  1. In leukapheresis products from non-Hodgkin's lymphoma patients, the immature hematopoietic progenitors show higher CD90 and CD34 antigenic expression

    Transfusion and Apheresis Science, Vol. 37, Núm. 2, pp. 145-156

  2. Short-term endothelial progenitor cell colonies are composed of monocytes and do not acquire endothelial markers

    Cytotherapy, Vol. 9, Núm. 1, pp. 14-22

2006

  1. Bone marrow mesenchymal stem cells chimerism after allogeneic hematopoietic transplantation

    Experimental Hematology

  2. Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines

    Blood, Vol. 107, Núm. 9, pp. 3575-3583

2005

  1. Long-term bone marrow culture data are the most powerful predictor of peripheral blood progenitor cell mobilization in healthy donors

    Haematologica, Vol. 90, Núm. 3, pp. 353-359

  2. Long-term immune recovery of patients undergoing allogeneic stem cell transplantation: A comparison with their respective sibling donors

    Biology of Blood and Marrow Transplantation, Vol. 11, Núm. 5, pp. 354-361

  3. Posttransplant hematopoiesis in patients undergoing sibling allogeneic stem cell transplantation reflects that of their respective donors although with a lower functional capability

    Experimental Hematology, Vol. 33, Núm. 8, pp. 935-943

2004

  1. Analysis of hematopoietic progenitor cells in patients with myelodysplastic syndromes according to their cytogenetic abnormalities

    Leukemia Research, Vol. 28, Núm. 11, pp. 1181-1187

  2. Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation

    Haematologica, Vol. 89, Núm. 12, pp. 1421-1427

2003

  1. Immunophenotypic analysis of myelodysplastic syndromes

    Haematologica, Vol. 88, Núm. 4, pp. 402-407